These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2844466)

  • 1. Bone status in nonambulant, epileptic, institutionalized youth. Improvement with vitamin D therapy.
    Fischer MH; Adkins WN; Liebl BH; VanCalcar SC; Marlett JA
    Clin Pediatr (Phila); 1988 Oct; 27(10):499-505. PubMed ID: 2844466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia.
    Collins N; Maher J; Cole M; Baker M; Callaghan N
    Q J Med; 1991 Feb; 78(286):113-22. PubMed ID: 1851568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology behind anticonvulsant osteomalacia.
    Christiansen C; Rødbro P; Tjellesen L
    Acta Neurol Scand Suppl; 1983; 94():21-8. PubMed ID: 6576595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy.
    Hoikka V; Savolainen K; Karjalainen P; Alhava EM; Sivenius J
    Ann Clin Res; 1982 Apr; 14(2):72-5. PubMed ID: 6983324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamazepine and bone mineral metabolism.
    Hoikka V; Alhava EM; Karjalainen P; Keränen T; Savolainen KE; Riekkinen P; Korhonen R
    Acta Neurol Scand; 1984 Aug; 70(2):77-80. PubMed ID: 6485747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone status of children receiving anticonvulsant therapy.
    Barden HS; Mazess RB; Chesney RW; Rose PG; Chun R
    Metab Bone Dis Relat Res; 1982; 4(1):43-7. PubMed ID: 7121254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vitamin D2 and D3 on bone-mineral content in carbamazepine-treated epileptic patients.
    Tjellesen L; Gotfredsen A; Christiansen C
    Acta Neurol Scand; 1983 Dec; 68(6):424-8. PubMed ID: 6320577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disorders of bone metabolism in severely handicapped children and young adults.
    Lee JJ; Lyne ED; Kleerekoper M; Logan MS; Belfi RA
    Clin Orthop Relat Res; 1989 Aug; (245):297-302. PubMed ID: 2752632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vitamin D on bone mineral mass in normal subjects and in epileptic patients on anticonvulsants: a controlled therapeutic trial.
    Christiansen C; Rodbro P; Lund M
    Br Med J; 1973 Apr; 2(5860):208-9. PubMed ID: 4573205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral status measured by direct photon absorptiometry in institutionalized adults receiving long-term anticonvulsant therapy and multivitamin supplementation.
    Barden HS; Mazess RB; Rose PG; McAweeney W
    Calcif Tissue Int; 1980; 31(2):117-21. PubMed ID: 6770975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral in mentally retarded patients receiving long-term anticonvulsive therapy.
    Barden HS; Smith E
    Growth; 1975 Sep; 39(3):371-88. PubMed ID: 1183855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment.
    Weinstein RS; Bryce GF; Sappington LJ; King DW; Gallagher BB
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1003-9. PubMed ID: 6725504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
    Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant osteomalacia in epileptic outpatients.
    Hoikka V; Savolainen K; Alhava EM; Sivenius J; Karjalainen P; Parvianinen M
    Ann Clin Res; 1982 Jun; 14(3):129-32. PubMed ID: 7137882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy].
    Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin D.
    Davie MW; Emberson CE; Lawson DE; Roberts GE; Barnes JL; Barnes ND; Heeley AF
    Q J Med; 1983; 52(205):79-91. PubMed ID: 6603629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased bone density in severely handicapped children and adults, with reference to the influence of limited mobility and anticonvulsant medication.
    Nishiyama S; Kuwahara T; Matsuda I
    Eur J Pediatr; 1986 Feb; 144(5):457-63. PubMed ID: 3007152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influences of bone and mineral metabolism in epilepsy.
    Hamed SA
    Expert Opin Drug Saf; 2011 Mar; 10(2):265-80. PubMed ID: 21323472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray photodensitometric analysis of anticonvulsant-induced osteopathy.
    Iwata Y; Amano K; Kawamura H; Tanikawa T; Kawabatake H; Notani M; Iseki H; Shiwaku T; Nagao T; Taira T
    Jpn J Psychiatry Neurol; 1988 Sep; 42(3):594-6. PubMed ID: 3241486
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation.
    Vogelsang H; Ferenci P; Resch H; Kiss A; Gangl A
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):609-14. PubMed ID: 8590154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.